Korean J Gastroenterol.  2017 Jan;69(1):64-67. 10.4166/kjg.2017.69.1.64.

Patient Monitoring and Associated Devices during Endoscopic Sedation

• Moon SH
• Kim HK
• Myung DS
• Yoon SM
• Moon W

• KMID: 2383433
• DOI: http://doi.org/10.4166/kjg.2017.69.1.64

Abstract

Sedation is an essential component for gastrointestinal endoscopy. It allows patients to tolerate unpleasant endoscopic procedures by relieving anxiety, discomfort, or pain. It also reduces patient's risk of physical injury during endoscopic procedures, while providing the endoscopist with an adequate setting for a detailed examination. For the safety during endoscopic sedation, patient monitoring is crucial. Minimal monitoring requirements during endoscopic sedation are periodic assessment of blood pressure and application of continuous pulse oximetry. Continuous electrocardiography is recommended in selected patients with high risk for sedation or have cardiopulmonary diseases. Continuous supplemental oxygen is also recommended for endoscopic sedation. This study describes detailed monitoring and associated devices based on the current guidelines and recommendations from gastrointestinal society of America, Europe, and Korea.

Keyword

Conscious sedation; Endoscopy; Patients; Monitoring; Device

MeSH Terms

Americas
Anxiety
Blood Pressure
Conscious Sedation
Electrocardiography
Endoscopy
Endoscopy, Gastrointestinal
Europe
Humans
Korea
Monitoring, Physiologic*
Oximetry
Oxygen
Oxygen

Reference

References

1. Rex DK. Review article: moderate sedation for endoscopy: sedation regimens for non-anaesthesiologists. Aliment Pharmacol Ther. 2006; 24:163–171.

2. Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology. 2007; 133:675–701.

3. Jung HK, Bae KS, Yoon SJ, Lee JS, Kwon JM, Yoo MA. Comparison of midazolam versus midazolam/meperidine during colonoscopy in a prospective, randomized, double-blind study. Korean J Gastroenterol. 2004; 43:96–103.

4. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002; 96:1004–1017.

5. Waring JP, Baron TH, Hirota WK, et al. Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc. 2003; 58:317–322.

6. Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy. Lichtenstein DR, Jagannath S, et al. Sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2008; 68:815–826.

7. Vargo JJ, DeLegge MH, Feld AD, et al. Multisociety sedation curriculum for gastrointestinal endoscopy. Gastrointest Endosc. 2012; 76:e1–e25.

8. Riphaus A, Wehrmann T, Weber B, et al. S3-guidelines–sedation in gastrointestinal endoscopy. Z Gastroenterol. 2008; 46:1298–1330.

9. Dumonceau JM, Riphaus A, Aparicio JR, et al. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy. 2010; 42:960–974.

10. Dumonceau JM, Riphaus A, Schreiber F, et al. Non-anesthesiolo-gist administration of propofol for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline–Updated June 2015. Endoscopy. 2015; 47:1175–1189.

11. Pelosi P. Retraction of endorsement: European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy. 2012; 44:302. author reply 302.

12. Byrne MF, Chiba N, Singh H, Sadowski DC. Clinical Affairs Committee of the Canadian Association of Gastroenterology. Propofol use for sedation during endoscopy in adults: a Canadian Association of Gastroenterology position statement. Can J Gastroenterol. 2008; 22:457–459.

13. Igea F, Casellas JA, Gonzalez-Huix F, et al. Sedation for gastrointestinal endoscopy. Endoscopy. 2014; 46:720–731.

14. Korean Society of Gastrointestinal Endoscopy Task Force on Sedation. A guidebook on sedation for gastrointestinal endoscopy. Seoul: Korean Society of Gastrointestinal Endoscopy;2015.

15. Korean Medical Association. Practice guideline for propofol sedation. Seoul: Korean Medical Association;2016.

16. Lee CK, Dong SH, Kim ES, et al. Room for quality improvement in endoscopist-directed sedation: results from the first nationwide survey in Korea. Gut Liver. 2016; 10:83–94.

17. Chan ED, Chan MM. Pulse oximetry: understanding its basic principles facilitates appreciation of its limitations. Respir Med. 2013; 107:789–799.

18. Sinex JE. Pulse oximetry: principles and limitations. Am J Emerg Med. 1999; 17:59–67.

19. Jang SY, Park HG, Jung MK, et al. Bispectral index monitoring as an adjunct to nurse-administered combined sedation during endoscopic retrograde cholangiopancreatography. World J Gastroenterol. 2012; 18:6284–6289.

20. von Delius S, Salletmaier H, Meining A, et al. Bispectral index monitoring of midazolam and propofol sedation during endoscopic retrograde cholangiopancreatography: a randomized clinical trial (the EndoBIS study). Endoscopy. 2012; 44:258–264.

21. Park JH Kim HJ, Seo JS. Medicolegal review of deaths related to propofol administration: analysis of 36 autopsied cases. Korean J Leg Med. 2012; 36:56–62.